BIOBETTER

Company Overview

The company uses tobacco crop plants to produce animal-free growth factors and proteins. BioBetter has developed a unique purification process that helps to produce animal-free growth factors and proteins. BioBetter focuses on plant-based cell-cultured meat production, industrial production of insulin, reduced manufacturing costs and collaboration with leading cultivated meat companies. The company has a manufacturing plant with the capacity to process 100kg of tobacco crop-derived growth factors on a daily basis. BioBetter produces and distributes molecular farming products according to ISO2200 and HACCP standards. In September 2022, BioBetter raised $10 million in a series A funding. This funding round is headed by Jerusalem Venture Partners.

Company's Business Segments

• Agri-tech based Products : The company develop bioactive proteins and growth factors (GFs) using a plant-based molecular farming platform.